Patent. JP2018027959A 【IF: 0】Patent. JP2018027959A 2018 Feb 22 Tofacitinib purchased from AbMole
2036 Extracellular matrix as a novel approach to glioma therapy 【IF: 0】J Clin Transl Sci. 2018 Nov 21;Vol2, Supplement S1, pp.11-12 Temozolomide purchased from AbMole
Patent. WO2018091677A1 【IF: 0】Patent. WO2018091677A1 2018 May 24 Y-27632 dihydrochloride purchased from AbMole
Targeting APC loss using synthetic lethality in Colorectal Cancer 【IF: 0】Queen Mary University of London. 2018 Feb Moxifloxacin hydrochloride purchased from AbMole
Orthotopic patient-derived xenografts of paediatric solid tumours 【IF: 69.504】Nature. 2017 Sep 7;549(7670):96-100 Adavosertib (MK-1775) purchased from AbMole
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 【IF: 69.504】Nature. 2017 Dec 6 NMS-873 purchased from AbMole
The target landscape of clinical kinase drugs 【IF: 63.714】Science. 2017 Dec 1;358(6367) X-376 purchased from AbMole
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models 【IF: 41.444】Mol Cancer. 2017 May 22;16(1):93 GDC-0941 (Pictilisib) purchased from AbMole
Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer’s disease 【IF: 14.957】Sci Adv. 2017 Feb 24;3(2):e1601068 Semagacestat purchased from AbMole
SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling 【IF: 13.965】Circ Res. 2017 Jul 31 DAPT purchased from AbMole
ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma. 【IF: 13.312】Cancer Res. 2017 Jun 1;77(11):3040-3056 VE-822 (Berzosertib) purchased from AbMole
ATM deficiency generating genomic instability sensitizes pancreatic ductal adenocarcinoma cells to therapy-induced DNA damage 【IF: 13.312】Cancer Res. 2017 Oct 15;77(20):5576-5590 VE-822 (Berzosertib) purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
